Ampio Pharmaceuticals, Inc.

AMPEOTCHealthcare● Active

$0.18

+$0.00(+0.00%)

Market Cap$207884

P/E Ratio—

52W High$0.6435

52W Low$0.0001

Avg Volume154

Open$0.01

Beta6.07

Cash on Hand Financials Revenue

Ampio Pharmaceuticals, Inc. (AMPE) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

AMPE · cash on hand · updated Dec 31, 2023

Core cash position

as of Dec 31, 2023

Cash & Short-Term Investments (CCE + ST Investments)

$4.1M▼ -67.7% vs prior year

FY · as of Dec 31, 2023 · Reported in USD

Cash & Cash Equiv. (CCE)

$4.1M

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

-67.7%

vs prior fiscal year

Latest Quarter

$4.1M

Q4 2023

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2023

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$4.1MCash on Hand

Total Debt$274,000Total Debt

Net Cash / Net Debt+$3.8MNet Cash Position

Cash vs Debt Ratio

Cash 94%Ampio Pharmaceuticals, Inc. cash as % of market cap: 1966.96%% · MCap $0BDebt 6%

Ampio Pharmaceuticals, Inc. has a net cash position of $3.8M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$4.1M − $274,000 = +$3.8M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

AMPE annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

AMPE cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2023LatestFY$4.1M-67.7%

Dec 31, 2022FY$12.7M-62.7%

Dec 31, 2021FY$33.9M+95.4%

Dec 31, 2020FY$17.3M+165.6%

Dec 31, 2019FY$6.5M-13.9%

AMPE cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

AMPE vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Ampio Pharmaceuticals, Inc.YOU

AMPE

$4.1M$0M1967.0%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Ampio Pharmaceuticals, Inc. (AMPE) cash on hand as of December 31, 2023 is $4.1M, comprising $4.1M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Ampio Pharmaceuticals, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Ampio Pharmaceuticals, Inc. cash reserves or cash position.

Ampio Pharmaceuticals, Inc. annual cash on hand history shows decreased -67.7% in 2023: decreased -67.7% in 2023. Ampio Pharmaceuticals, Inc. cash reserves in 2023 reflect the company's capital allocation strategy.

Ampio Pharmaceuticals, Inc. carries total debt of $274,000 against cash of $4.1M, resulting in a net cash position of +$3.8M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

AMPE cash on hand · 5 questions

As of December 31, 2023, Ampio Pharmaceuticals, Inc. (AMPE) has $4,089,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $4,089,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (December 31, 2023): $4,089,000. Data sourced from the annual 10-K filing via FMP.

AMPE cash on handAMPE cash reservesAMPE cash 2023how much cash does AMPE have

▸ Source: FMP /balance-sheet-statement · US GAAP · Ampio Pharmaceuticals, Inc. · Ampio Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2023